Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors.
Pharmaceuticals (Basel)
; 15(10)2022 Oct 13.
Article
en En
| MEDLINE
| ID: mdl-36297372
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Año:
2022
Tipo del documento:
Article